Analysts think NVAX stock price could increase by 152%
Mar 05, 2025, 12:25 PM
-27.15%
What does NVAX do
Novavax is a biotechnology company based in Gaithersburg, Maryland, focused on developing recombinant vaccines, including its COVID-19 vaccines Nuvaxovid and other candidates. The company employs 1,543 people and utilizes advanced nanoparticle technology and its Matrix-M adjuvant to enhance immune responses.
9 analysts think NVAX stock price will increase by 152.34%. The current median analyst target is $19.38 compared to a current stock price of $7.68. The lowest analysts target is $9.09 and the highest analyst target is $26.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
